A longitudinal study using data from the Alzheimer’s Disease Neuroimaging Initiative found that omega-3 fatty acid supplementation was associated with accelerated cognitive decline in older adults, challenging the common belief that omega-3 universally protects brain health. Participants taking omega-3 supplements showed faster worsening in MMSE, ADAS-Cog13, and CDR-SB scores over time. Interestingly, the association was not explained by classical Alzheimer’s disease pathologies such as amyloid-β accumulation, tau deposition, or gray matter atrophy. Instead, reduced cerebral glucose metabolism on FDG-PET scans—reflecting impaired synaptic and neuronal function in AD-vulnerable brain regions—partially mediated the relationship, accounting for 19% to 41% of the observed cognitive decline. These findings suggest that omega-3 supplementation may adversely affect cerebral synaptic function in some older adults and highlight the need for a more cautious reassessment of its widespread use for cognitive protection. Source: https://www.sciencedirect.com/
Accelerometer-derived sleep-wake cycle patterns were associated with a higher risk of future dementia and modestly…
Early initiation of sodium-glucose cotransporter-2 (SGLT2) inhibitors after Takotsubo syndrome was associated with significantly lower…
An updated Cochrane systematic review of five randomized controlled trials involving 341,342 men found that…
A US prospective study found that moderate egg consumption was associated with a significantly lower…
Anxiety disorders are common yet often underrecognized in primary care, but a review shows that…
Two-dose recombinant zoster vaccination (RZV) was associated with a significantly lower risk of new-onset dementia,…
This website uses cookies.